7921 SOUTHPARK PLAZA,, LITTLETON, CO
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Reports Full Year 2025 Financial Results
Vivos Therapeutics Enters into PIPE Agreement with V-Co Investors 3 LLC
Appointment of Gregg C. E. Johnson as Independent Director
Material Contracts, Unregistered Sales of Equity Securities
Vivos Therapeutics Enters $5.5M Convertible Promissory Note with V-Co
Announces Grand Opening of Affiliated Sleep Center Near Detroit, Michigan
Vivos Therapeutics Enters $2.09 Million Note Purchase Agreement
Q1
Notice of Late Filing for Quarterly Report
FY 2025
Q3
Q2
Effectiveness Notice
Prospectus filed pursuant to Rule 424(b)(3)
Amended Registration Statement for Securities Offered under a Shelf Registration
Registration Statement for Securities Offered under a Shelf Registration
Prospectus filed pursuant to Rule 424(b)(5)
Definitive Proxy Statement
Additional Proxy Materials
PRE 14A
Schedule 13G - Ownership Report
Initial Statement of Beneficial Ownership
Schedule 13D - Ownership Report
Statement of Changes in Beneficial Ownership
Post-Effective Amendment to Registration Statement
Correspondence
Submission Upload
Prospectus Filed Pursuant to Rule 424(b)(1)